Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Alessandro Armuzzi; Antonio Gasbarrini; Luisa Guidi; Rita Monterubbianesi; Annalisa Aratari; Marco Daperno; Livia Biancone; Maria Cappello; Vito Annese; Gabriele Riegler; Ambrogio Orlando; Angelo Viscido; Gianmichele Meucci; Alessandro Lavagna; Raffaello Sostegni; Sara Onali; Claudio Papi; Anna Kohn

doi:10.1016/j.crohns.2014.01.006

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

Alessandro Armuzzi, Antonio Gasbarrini, Luisa Guidi, Rita Monterubbianesi, Annalisa Aratari, Marco Daperno, Livia Biancone, Maria Cappello, Vito Annese, Gabriele Riegler, Ambrogio Orlando, Angelo Viscido, Gianmichele Meucci, Alessandro Lavagna, Raffaello Sostegni, Sara Onali, Claudio Papi, Anna Kohn

Risultato della ricerca: Contributo in rivista › Articolo in rivista

44 Citazioni (Scopus)

Abstract

Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.

Lingua originale	English
pagine (da-a)	852-858
Numero di pagine	7
Rivista	Journal of Crohn's and Colitis
Volume	8
DOI	https://doi.org/10.1016/j.crohns.2014.01.006
Stato di pubblicazione	Pubblicato - 2014

Keywords

Colectomy
Infliximab
Ulcerative colitis

Accesso al documento

10.1016/j.crohns.2014.01.006

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy'. Insieme formano una fingerprint unica.

Cita questo

Armuzzi, A., Gasbarrini, A., Guidi, L., Monterubbianesi, R., Aratari, A., Daperno, M., Biancone, L., Cappello, M., Annese, V., Riegler, G., Orlando, A., Viscido, A., Meucci, G., Lavagna, A., Sostegni, R., Onali, S., Papi, C., & Kohn, A. (2014). Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. Journal of Crohn's and Colitis, 8, 852-858. https://doi.org/10.1016/j.crohns.2014.01.006

Armuzzi, Alessandro ; Gasbarrini, Antonio ; Guidi, Luisa ; Monterubbianesi, Rita ; Aratari, Annalisa ; Daperno, Marco ; Biancone, Livia ; Cappello, Maria ; Annese, Vito ; Riegler, Gabriele ; Orlando, Ambrogio ; Viscido, Angelo ; Meucci, Gianmichele ; Lavagna, Alessandro ; Sostegni, Raffaello ; Onali, Sara ; Papi, Claudio ; Kohn, Anna. / Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. In: Journal of Crohn's and Colitis. 2014 ; Vol. 8. pagg. 852-858.

@article{3afe41c90a7a47158c328cea7d7eb524,

title = "Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy",

abstract = "Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.",

keywords = "Colectomy, Infliximab, Ulcerative colitis, Colectomy, Infliximab, Ulcerative colitis",

author = "Alessandro Armuzzi and Antonio Gasbarrini and Luisa Guidi and Rita Monterubbianesi and Annalisa Aratari and Marco Daperno and Livia Biancone and Maria Cappello and Vito Annese and Gabriele Riegler and Ambrogio Orlando and Angelo Viscido and Gianmichele Meucci and Alessandro Lavagna and Raffaello Sostegni and Sara Onali and Claudio Papi and Anna Kohn",

year = "2014",

doi = "10.1016/j.crohns.2014.01.006",

language = "English",

volume = "8",

pages = "852--858",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "NETHERLANDS: ELSEVIER SCIENCE",

}

Armuzzi, A , Gasbarrini, A , Guidi, L, Monterubbianesi, R, Aratari, A, Daperno, M, Biancone, L, Cappello, M, Annese, V, Riegler, G, Orlando, A, Viscido, A, Meucci, G, Lavagna, A, Sostegni, R, Onali, S, Papi, C & Kohn, A 2014, 'Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy', Journal of Crohn's and Colitis, vol. 8, pagg. 852-858. https://doi.org/10.1016/j.crohns.2014.01.006

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. / Armuzzi, Alessandro ; Gasbarrini, Antonio ; Guidi, Luisa; Monterubbianesi, Rita; Aratari, Annalisa; Daperno, Marco; Biancone, Livia; Cappello, Maria; Annese, Vito; Riegler, Gabriele; Orlando, Ambrogio; Viscido, Angelo; Meucci, Gianmichele; Lavagna, Alessandro; Sostegni, Raffaello; Onali, Sara; Papi, Claudio; Kohn, Anna.

In: Journal of Crohn's and Colitis, Vol. 8, 2014, pag. 852-858.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

AU - Armuzzi, Alessandro

AU - Gasbarrini, Antonio

AU - Guidi, Luisa

AU - Monterubbianesi, Rita

AU - Aratari, Annalisa

AU - Daperno, Marco

AU - Biancone, Livia

AU - Cappello, Maria

AU - Annese, Vito

AU - Riegler, Gabriele

AU - Orlando, Ambrogio

AU - Viscido, Angelo

AU - Meucci, Gianmichele

AU - Lavagna, Alessandro

AU - Sostegni, Raffaello

AU - Onali, Sara

AU - Papi, Claudio

AU - Kohn, Anna

PY - 2014

Y1 - 2014

N2 - Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.

AB - Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.

KW - Colectomy

KW - Infliximab

KW - Ulcerative colitis

KW - Colectomy

KW - Infliximab

KW - Ulcerative colitis

UR - http://hdl.handle.net/10807/60687

U2 - 10.1016/j.crohns.2014.01.006

DO - 10.1016/j.crohns.2014.01.006

M3 - Article

VL - 8

SP - 852

EP - 858

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

ER -